NeoVax

· Dana-Farber Cancer Institute

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NeoVax, covering 2025-06-18 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma [Phase 1]